The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Percentage of sarcomatoid component as a prognostic indicator for survival in sarcomatoid renal cell carcinoma.
 
Mehrad Adibi
No Relationships to Disclose
 
Arun Z. Thomas
No Relationships to Disclose
 
Leonardo Borregales
No Relationships to Disclose
 
Megan M. Merrill
No Relationships to Disclose
 
Kanishka Sircar
No Relationships to Disclose
 
Pheroze Tamboli
No Relationships to Disclose
 
Rebecca Slack
No Relationships to Disclose
 
Hsiang-Chun Chen
No Relationships to Disclose
 
Nizar M. Tannir
No Relationships to Disclose
 
Eric Jonasch
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Exelixis; GlaxoSmithKline; Novartis; Onyx; Pfizer
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Pfizer
 
Surena F. Matin
No Relationships to Disclose
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Jose A. Karam
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer